Geratherm Medical AG/LMT Medical (ISIN: DE 0005495626): LMT Medical, a subsidiary of Geratherm Medical AG, has received product approval for the Chinese market for its MRI-capable incubator system for newborns. The basis for the approval, which was granted over a period of five years, was, among other things, a successful clinical study conducted in China. With the LMT product, incubator system nomag® IC, premature and newborn infants can be examined directly in MRI - Magnetic Resonance Tomography - to diagnose any possible brain or organ damage. This is currently a unique solution worldwide. To date, more than 100 LMT Medical systems are in use worldwide. The Chinese market is considered one of the largest future markets for these systems. The approval will already have a positive impact on the company's sales development in 2021.